Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Hair loss needs more research for better treatments.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Future acne treatments should aggressively target inflammation to prevent scarring.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Spironolactone can reduce hair growth in women with hirsutism.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

Minoxidil helps hair growth and reduces shedding in women.

Finasteride helps reduce heart issues and improves heart function.

Minoxidil helps lower high blood pressure in kids, but can cause fluid retention and hair growth.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.